Request for Covid-19 Impact Assessment of this Report
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antibody Drug Conjugates in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Antibody Drug Conjugates market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
F.Hoffman-La Roche
Novartis
Takeda Pharmaceutial
Pfizer
Seattle Genetics
Genentech
Immunogen
Immunomedics
Progenics Pharmaceutical
Bayer Healthcare Pharmaceutical
Agensys
Concortis Biotherapeutics
Sanofi
Celldex Therapeutics
Synthon Holding
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adcetris
Kadcyla
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Antibody Drug Conjugates for each application, including
Breast Cancer
Lymphoma
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Antibody Drug Conjugates Market Research Report 2017
1 Antibody Drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody Drug Conjugates
1.2 Antibody Drug Conjugates Segment by Type (Product Category)
1.2.1 Global Antibody Drug Conjugates Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Antibody Drug Conjugates Production Market Share by Type (Product Category) in 2016
1.2.3 Adcetris
1.2.4 Kadcyla
1.3 Global Antibody Drug Conjugates Segment by Application
1.3.1 Antibody Drug Conjugates Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody Drug Conjugates Market by Region (2012-2022)
1.4.1 Global Antibody Drug Conjugates Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Antibody Drug Conjugates (2012-2022)
1.5.1 Global Antibody Drug Conjugates Revenue Status and Outlook (2012-2022)
1.5.2 Global Antibody Drug Conjugates Capacity, Production Status and Outlook (2012-2022)
2 Global Antibody Drug Conjugates Market Competition by Manufacturers
2.1 Global Antibody Drug Conjugates Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Antibody Drug Conjugates Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Antibody Drug Conjugates Production and Share by Manufacturers (2012-2017)
2.2 Global Antibody Drug Conjugates Revenue and Share by Manufacturers (2012-2017)
2.3 Global Antibody Drug Conjugates Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Antibody Drug Conjugates Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antibody Drug Conjugates Market Competitive Situation and Trends
2.5.1 Antibody Drug Conjugates Market Concentration Rate
2.5.2 Antibody Drug Conjugates Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Antibody Drug Conjugates Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Antibody Drug Conjugates Capacity and Market Share by Region (2012-2017)
3.2 Global Antibody Drug Conjugates Production and Market Share by Region (2012-2017)
3.3 Global Antibody Drug Conjugates Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Antibody Drug Conjugates Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Antibody Drug Conjugates Consumption by Region (2012-2017)
4.2 North America Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.3 Europe Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.4 China Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.5 Japan Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.7 India Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)
5 Global Antibody Drug Conjugates Production, Revenue (Value), Price Trend by Type
5.1 Global Antibody Drug Conjugates Production and Market Share by Type (2012-2017)
5.2 Global Antibody Drug Conjugates Revenue and Market Share by Type (2012-2017)
5.3 Global Antibody Drug Conjugates Price by Type (2012-2017)
5.4 Global Antibody Drug Conjugates Production Growth by Type (2012-2017)
6 Global Antibody Drug Conjugates Market Analysis by Application
6.1 Global Antibody Drug Conjugates Consumption and Market Share by Application (2012-2017)
6.2 Global Antibody Drug Conjugates Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Antibody Drug Conjugates Manufacturers Profiles/Analysis
7.1 F.Hoffman-La Roche
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Antibody Drug Conjugates Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 F.Hoffman-La Roche Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Novartis
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Antibody Drug Conjugates Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Takeda Pharmaceutial
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Antibody Drug Conjugates Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Takeda Pharmaceutial Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Pfizer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Antibody Drug Conjugates Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Pfizer Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Seattle Genetics
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Antibody Drug Conjugates Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Seattle Genetics Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Genentech
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Antibody Drug Conjugates Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Genentech Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Immunogen
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Antibody Drug Conjugates Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Immunogen Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Immunomedics
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Antibody Drug Conjugates Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Immunomedics Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Progenics Pharmaceutical
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Antibody Drug Conjugates Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Progenics Pharmaceutical Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Bayer Healthcare Pharmaceutical
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Antibody Drug Conjugates Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Agensys
7.12 Concortis Biotherapeutics
7.13 Sanofi
7.14 Celldex Therapeutics
7.15 Synthon Holding
8 Antibody Drug Conjugates Manufacturing Cost Analysis
8.1 Antibody Drug Conjugates Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antibody Drug Conjugates
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Antibody Drug Conjugates Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Antibody Drug Conjugates Market Forecast (2017-2022)
12.1 Global Antibody Drug Conjugates Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Antibody Drug Conjugates Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Antibody Drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Antibody Drug Conjugates Price and Trend Forecast (2017-2022)
12.2 Global Antibody Drug Conjugates Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Antibody Drug Conjugates Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Antibody Drug Conjugates Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Figure Picture of Antibody Drug Conjugates
Figure Global Antibody Drug Conjugates Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Antibody Drug Conjugates Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Adcetris
Table Major Manufacturers of Adcetris
Figure Product Picture of Kadcyla
Table Major Manufacturers of Kadcyla
Figure Global Antibody Drug Conjugates Consumption (K Units) by Applications (2012-2022)
Figure Global Antibody Drug Conjugates Consumption Market Share by Applications in 2016
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Global Antibody Drug Conjugates Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Antibody Drug Conjugates Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Antibody Drug Conjugates Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Antibody Drug Conjugates Major Players Product Capacity (K Units) (2012-2017)
Table Global Antibody Drug Conjugates Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Antibody Drug Conjugates Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Antibody Drug Conjugates Capacity (K Units) of Key Manufacturers in 2016
Figure Global Antibody Drug Conjugates Capacity (K Units) of Key Manufacturers in 2017
Figure Global Antibody Drug Conjugates Major Players Product Production (K Units) (2012-2017)
Table Global Antibody Drug Conjugates Production (K Units) of Key Manufacturers (2012-2017)
Table Global Antibody Drug Conjugates Production Share by Manufacturers (2012-2017)
Figure 2016 Antibody Drug Conjugates Production Share by Manufacturers
Figure 2017 Antibody Drug Conjugates Production Share by Manufacturers
Figure Global Antibody Drug Conjugates Major Players Product Revenue (Million USD) (2012-2017)
Table Global Antibody Drug Conjugates Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Antibody Drug Conjugates Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Antibody Drug Conjugates Revenue Share by Manufacturers
Table 2017 Global Antibody Drug Conjugates Revenue Share by Manufacturers
Table Global Market Antibody Drug Conjugates Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Antibody Drug Conjugates Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Antibody Drug Conjugates Manufacturing Base Distribution and Sales Area
Table Manufacturers Antibody Drug Conjugates Product Category
Figure Antibody Drug Conjugates Market Share of Top 3 Manufacturers
Figure Antibody Drug Conjugates Market Share of Top 5 Manufacturers
Table Global Antibody Drug Conjugates Capacity (K Units) by Region (2012-2017)
Figure Global Antibody Drug Conjugates Capacity Market Share by Region (2012-2017)
Figure Global Antibody Drug Conjugates Capacity Market Share by Region (2012-2017)
Figure 2016 Global Antibody Drug Conjugates Capacity Market Share by Region
Table Global Antibody Drug Conjugates Production by Region (2012-2017)
Figure Global Antibody Drug Conjugates Production (K Units) by Region (2012-2017)
Figure Global Antibody Drug Conjugates Production Market Share by Region (2012-2017)
Figure 2016 Global Antibody Drug Conjugates Production Market Share by Region
Table Global Antibody Drug Conjugates Revenue (Million USD) by Region (2012-2017)
Table Global Antibody Drug Conjugates Revenue Market Share by Region (2012-2017)
Figure Global Antibody Drug Conjugates Revenue Market Share by Region (2012-2017)
Table 2016 Global Antibody Drug Conjugates Revenue Market Share by Region
Figure Global Antibody Drug Conjugates Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Antibody Drug Conjugates Consumption (K Units) Market by Region (2012-2017)
Table Global Antibody Drug Conjugates Consumption Market Share by Region (2012-2017)
Figure Global Antibody Drug Conjugates Consumption Market Share by Region (2012-2017)
Figure 2016 Global Antibody Drug Conjugates Consumption (K Units) Market Share by Region
Table North America Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Antibody Drug Conjugates Production (K Units) by Type (2012-2017)
Table Global Antibody Drug Conjugates Production Share by Type (2012-2017)
Figure Production Market Share of Antibody Drug Conjugates by Type (2012-2017)
Figure 2016 Production Market Share of Antibody Drug Conjugates by Type
Table Global Antibody Drug Conjugates Revenue (Million USD) by Type (2012-2017)
Table Global Antibody Drug Conjugates Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Antibody Drug Conjugates by Type (2012-2017)
Figure 2016 Revenue Market Share of Antibody Drug Conjugates by Type
Table Global Antibody Drug Conjugates Price (USD/Unit) by Type (2012-2017)
Figure Global Antibody Drug Conjugates Production Growth by Type (2012-2017)
Table Global Antibody Drug Conjugates Consumption (K Units) by Application (2012-2017)
Table Global Antibody Drug Conjugates Consumption Market Share by Application (2012-2017)
Figure Global Antibody Drug Conjugates Consumption Market Share by Applications (2012-2017)
Figure Global Antibody Drug Conjugates Consumption Market Share by Application in 2016
Table Global Antibody Drug Conjugates Consumption Growth Rate by Application (2012-2017)
Figure Global Antibody Drug Conjugates Consumption Growth Rate by Application (2012-2017)
Table F.Hoffman-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F.Hoffman-La Roche Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Production Market Share (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Novartis Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Novartis Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Takeda Pharmaceutial Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutial Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Pfizer Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Genentech Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Genentech Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Immunogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunogen Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunogen Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Immunogen Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Immunogen Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Immunomedics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Progenics Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Progenics Pharmaceutical Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Bayer Healthcare Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Production Growth Rate (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Production Market Share (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugates
Figure Manufacturing Process Analysis of Antibody Drug Conjugates
Figure Antibody Drug Conjugates Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2016
Table Major Buyers of Antibody Drug Conjugates
Table Distributors/Traders List
Figure Global Antibody Drug Conjugates Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Antibody Drug Conjugates Price (Million USD) and Trend Forecast (2017-2022)
Table Global Antibody Drug Conjugates Production (K Units) Forecast by Region (2017-2022)
Figure Global Antibody Drug Conjugates Production Market Share Forecast by Region (2017-2022)
Table Global Antibody Drug Conjugates Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Antibody Drug Conjugates Consumption Market Share Forecast by Region (2017-2022)
Figure North America Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Antibody Drug Conjugates Production (K Units) Forecast by Type (2017-2022)
Figure Global Antibody Drug Conjugates Production (K Units) Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugates Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Antibody Drug Conjugates Revenue Market Share Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugates Price Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugates Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Antibody Drug Conjugates Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...